echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Sinovac Pharma Human Interferon α2b Spray Phase I clinical trial completed the enrollment of the first subject

    Sinovac Pharma Human Interferon α2b Spray Phase I clinical trial completed the enrollment of the first subject

    • Last Update: 2022-12-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, Sinovac Biopharmaceutical Co.
    , Ltd.
    (hereinafter referred to as the "Company") developed a phase I clinical study of human interferon α2b spray successfully completed the first subject enrollment administration
    .

    Human interferon α2b spray is a two-class improved new drug independently developed by the company, which optimizes the dosage form and route of administration of the listed drug, increases the drug concentration at the lesion site through targeted topical administration, is easy to use and carry, has good patient compliance, and has obvious clinical advantages
    .

    The company's human interferon alpha 2b spray is indicated for the treatment of initial or recurrent cutaneous herpes simplex (cold sores and genital herpes)
    caused by viruses.

    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.